Navigation Links
BD Announces Results for Fourth Fiscal Quarter and Full Year
Date:11/4/2009

1,048,676 1,037,968 1.0 ---------------- --------- --------- --- TOTAL $2,226,219 $2,159,811 3.1 ----- ---------- ---------- --- BD BIOSCIENCES -------------- United States $449,151 $470,641 (4.6) International 754,658 724,455 4.2 ---------------- ------- ------- --- TOTAL $1,203,809 $1,195,096 0.7 ----- ---------- ---------- --- TOTAL REVENUES -------------- United States $3,204,680 $3,116,688 2.8 International 3,956,194 3,958,254 (0.1) ---------------- --------- --------- ---- TOTAL $7,160,874 $7,074,942 1.2 ----- ---------- ---------- --- BECTON DICKINSON AND COMPANY SUPPLEMENTAL REVENUE INFORMATION REVENUES BY BUSINESS SEGMENTS AND UNITS Three Months Ended September 30, (Unaudited; Amounts in thousands) United States ---------------------------- 2009 2008 % Change -------- -------- ---------- BD MEDICAL ---------- Medical Surgical Systems $267,070 $248,111 7.6 Diabetes Care 88,590 82,445 7.5 Pharmaceutical Systems 48,353 37,512 28.9 Ophthalmic Systems 6,912 6,419 7.7 --------------------- ----- ----- --- TOTAL
'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...Nov. 29 Royal Philips Electronics ...n industry need by showing its portfolio of produc...s 95th annual meeting of the Radiological Society ... from Philips are several advancements and upgrade...iation and streamlining workflow to expand upon cl...
(Date:11/29/2009)... 29 This year at the Radiological ...y and Annual Meeting, FUJIFILM Medical Systems USA...alization space with the introduction of Synapse(T... in image processing by now offering its own advan...phic and cardiovascular applications. The company...
(Date:11/27/2009)...inn, Nov. 27 ACUO TECHNOLOGIES, de...ent software, data migration tools and services, i...t and Trademark Office has approved a patent appli... Computer Network." Acuo Technologies is pleased t...tual property. In general, the granted patent appl...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3Elbit Imaging Ltd Announces Interest Rate for the Next Interest Period for Series B Notes 13712 1Elbit Imaging Ltd Announces Interest Rate for the Next Interest Period for Series B Notes 13712 2Elbit Imaging Ltd Announces Interest Rate for the Next Interest Period for Series B Notes 13712 3
...uesday, May 13 at 1:00 p.m. EDT ...ENLO PARK, Calif., May 13 /PRNewswire-FirstCall/,-...itive six-month follow-up,data from the CUSTOM III...icacy of the Custom NX(R) drug eluting stent (DES)...y artery disease., The CUSTOM III clinical trial ...
...II Trial Experience Better, Long-Term Clinical Out...ts Treated with TAXUS, ... for the first time today from the SPIRIT III tria...(TM) V Everolimus Eluting Coronary Stent,System, d...nically superior,benefits for patients compared to...
Other Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5
(Date:11/28/2009)...- Welcome to syngo® .plaza(1), the ne...rom Siemens Healthcare. As the first Picture A...iemens where 2D, 3D, and 4D reading come together ...e the way multimodality images are read today. Sie...ientific Assembly and Annual Meeting of the Radiol...
(Date:11/27/2009)...ire-FirstCall/ -- GSI Group Inc. (Pink Sheets: GSI...logy products and semiconductor systems, today ann...reholders has been scheduled for Friday, April 30,...be announced in due course. As previously announc... Stephen Bershad, a holder of greater than ten per...
(Date:11/27/2009)...ire-USNewswire/ -- Preventing disease is the goal ...y year, new vaccines are being added to assist in ...nity for the same period of time? And, if not, whe...munity strong? ,, In this month,s issue of Pe...ediatrics, Michael Pichichero MD, Director of the ...
(Date:11/27/2009)... economic burdens, study predicts , , FR...ople with diabetes in the United States is expecte...edicts. , That would bring the total by 2034 to...om 23.7 million today. , , At the same time, the..., the study also warns, rising from an estimated $...
(Date:11/27/2009)...ve anatomy education apps from Modality and Lippin... learning opportunities for iPhone and iPod touch ...mber 27, 2009 -- Modality, Inc. and Lippincott W... Kluwer Health, today announced the availability o...e. Clemente’s Anatomy, Rohen’s Photogr...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...and MILPITAS, Calif., Sept. 27 ,Flextronics Intern...ation,(NYSE: SLR ) today announced that Flextroni...proved the completion of Flextronics,s proposed,ac...as of June 4, 2007. Flextronics shareholders, at t...
...3,000 leading scientists and clinicians to present...., Sept. 27 - An international,medical meeting wil...m all,fields of science and medicine to Anaheim Oc...sis Conference is an annual,ritual for leading CF ...
...Sept. 27 Bristol-Myers Squibb,(NYSE: BMY ) annou...mpany,s,Research and Development organization as s... and Licensing. He will report to Dr. Elliott Siga...for Bristol-Myers Squibb, as we look to further bu...
...s leading cause of parasitic infections in U.S. , ...have sequenced the genome of the intestinal parasi...,000 reported infections a year in the United Stat...Giardia through contact with infected stool or by ...
...ER, Mass. Several recent research studies publishe...adolescents who see smoking scenes in movies are m...h, public health groups have called for Restricted...ot have the intended effect of putting such movies...
... Real Estate Services Firm Assembles Veteran Healt...dership, CHICAGO, Sept. 27 Alter+Care, one of th...nt firms, has established an,Advisory Board to pro..., announced the Alter+Care Advisory Board,s format...
Other Medicine News:Health News:Flextronics Shareholders and Solectron Stockholders Approve Acquisition 2Health News:Flextronics Shareholders and Solectron Stockholders Approve Acquisition 3Health News:Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting 2Health News:Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing 2Health News:Scientists Map Intestinal Bug's Genome 2Health News:R rating might be unlikely to affect teens exposure to smoking in movies 2Health News:Alter+Care Creates the Advisory Board 2Health News:Alter+Care Creates the Advisory Board 3
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: